# Pyrazinamide

## Pyrazinamide 500mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                         |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OPYRZ                                                                                                                                                                                                                                                                                           |
| Indications        | Treatment of pulmonary & extrapulmonary TB.                                                                                                                                                                                                                                                     |
| Dosing             | (仿單) 1500-2000 mg/day (3-4 tablets) divided into 1-3 doses. (熱病) Adult: 25 mg/kg po q24h (max. 2.5 g/day). Pediatric: 15-30 mg/kg/day (once daily， max. 2 g/day) or 50 mg/kg twice weekly (max. 2 g/day).                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to pyrazinamide or any component of the formulation; acute gout; severe hepatic damage                                                                                                                                                                                         |
| Adverse Effects    | Hepatotoxicity， jaundice， hyperuricemia leading to attacks of gout， anorexia， nausea， vomiting， arthralgia， malaise， fever， sideroblastic anemia， difficulty in micturition. Endocrine metabolic: Hyperuricemia Gastrointestinal: Nausea， Vomiting Musculoskeletal: Arthralgia (40%) |
| Pregnancy          | Compatible – maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                   |

